Dr. Glenn Michelson joined Notable as chief medical officer in 2023. With more than 25 years of experience in the pharmaceutical industry, Glenn specializes in oncology and clinical trials, bringing extensive expertise to his role at Notable.
Michelson began his career at Agouron/Pfizer, progressing from medical director to vice president of clinical development. He has held senior positions at established biopharma companies including Cell Therapeutics, Chiron, Sunesis, Portola and Genentech, and served as chief medical officer at Plexxikon. In 2018, he founded Audentes Consulting to share his expertise in oncology clinical development with startups and smaller companies.
Michelson completed his residency in internal medicine at the University of Pittsburgh and his medical oncology/hematology fellowship at the University of Chicago. He earned a bachelor of science degree in chemistry and a doctor of medicine degree from the University of Louisville, Louisville, Ky.
